Genesis IBRC India [GENESIS] vs Zota Health Care [ZOTA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Genesis IBRC India Ltd. wins in 10 metrics, Zota Health Care Limited wins in 4 metrics, with 1 ties. Genesis IBRC India Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genesis IBRC India Ltd. | Zota Health Care Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.89 | -62.53 | Genesis IBRC India Ltd. |
| Price-to-Book Ratio | 9.93 | 12.61 | Genesis IBRC India Ltd. |
| Debt-to-Equity Ratio | 0.00 | 56.90 | Tie |
| PEG Ratio | N/A | -0.59 | N/A |
| EV/EBITDA | 26.95 | -126.59 | Genesis IBRC India Ltd. |
| Profit Margin (TTM) | 2.36% | -15.37% | Genesis IBRC India Ltd. |
| Operating Margin (TTM) | -11.05% | -15.88% | Genesis IBRC India Ltd. |
| Return on Equity | 0.08% | -24.83% | Genesis IBRC India Ltd. |
| Return on Assets (TTM) | 0.05% | -12.84% | Genesis IBRC India Ltd. |
| Free Cash Flow (TTM) | $-3,000 | $-959.42M | Genesis IBRC India Ltd. |
| Dividend Yield | N/A | 0.07% | N/A |
| 1-Year Return | 507.27% | 12.58% | Genesis IBRC India Ltd. |
| Price-to-Sales Ratio (TTM) | 1,399.83 | 8.34 | Zota Health Care Limited |
| Enterprise Value | $944.70M | $45.66B | Zota Health Care Limited |
| EV/Revenue Ratio | 326.10 | 9.66 | Zota Health Care Limited |
| Gross Profit Margin (TTM) | N/A | 60.28% | N/A |
| Revenue per Share (TTM) | $0 | $157 | Zota Health Care Limited |
| Earnings per Share (Diluted) | $-0.18 | $-23.94 | Genesis IBRC India Ltd. |
| Beta (Stock Volatility) | N/A | 0.36 | N/A |
Genesis IBRC India Ltd. vs Zota Health Care Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genesis IBRC India Ltd. | -4.96% | 0.00% | -0.51% | 54.94% | -14.33% | 37.72% |
| Zota Health Care Limited | 7.20% | -2.47% | -13.95% | -6.24% | -28.72% | -24.79% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genesis IBRC India Ltd. | 507.27% | 993.55% | 1,467.02% | 623.84% | 5,745.00% | 5,745.00% |
| Zota Health Care Limited | 12.58% | 278.03% | 548.16% | 1,137.98% | 1,137.98% | 1,137.98% |
Performance & Financial Health Analysis: Genesis IBRC India Ltd. vs Zota Health Care Limited
| Metric | GENESIS | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.47B | ₹39.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 250 | 56,411 |
| 90 Day Avg. Volume | 317 | 53,265 |
| Last Close | ₹111.10 | ₹1,225.60 |
| 52 Week Range | ₹19.25 - ₹181.30 | ₹917.20 - ₹1,740.00 |
| % from 52W High | -38.72% | -29.56% |
| All-Time High | ₹184.90 (Nov 11, 2025) | ₹1,740.00 (Nov 21, 2025) |
| % from All-Time High | -39.91% | -29.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.98% |
| Quarterly Earnings Growth | N/A | 1.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.15% |
| Operating Margin (TTM) | -0.11% | -0.16% |
| Return on Equity (TTM) | 0.00% | -0.25% |
| Debt to Equity (MRQ) | 0.00 | 56.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹9.02 | ₹103.04 |
| Cash per Share (MRQ) | ₹5.26 | ₹1.87 |
| Operating Cash Flow (TTM) | ₹0 | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹35.05M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.07% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Genesis IBRC India Ltd. vs Zota Health Care Limited
| Metric | GENESIS (Apr 24, 2026) | ZOTA (Apr 22, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.89 | -62.53 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | -0.59 |
| Price to Sales (TTM) | 1,399.83 | 8.34 |
| Price to Book (MRQ) | 9.93 | 12.61 |
| Market Capitalization | ||
| Market Capitalization | ₹4.47B | ₹39.41B |
| Enterprise Value | ₹944.70M | ₹45.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 326.10 | 9.66 |
| Enterprise to EBITDA | 26.95 | -126.59 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.36 |
| Book Value per Share (MRQ) | ₹9.02 | ₹103.04 |
Financial Statements Comparison: Genesis IBRC India Ltd. vs Zota Health Care Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GENESIS (2025) | ZOTA (2025) |
|---|---|---|
| Revenue/Sales | 0 | 2.93B |
| Cost of Goods Sold | 0 | 1.44B |
| COGS % of Revenue | - | 49.0% |
| Gross Profit | 0 | 1.49B |
| Gross Margin | - | 51.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 35.05M | -480.90M |
| Operating Margin | - | -16.4% |
| EBITDA | 35.05M | -42.20M |
| EBITDA Margin | - | -1.4% |
| Pre-Tax Income | 35.05M | -576.44M |
| Pre-Tax Income % of Revenue | - | -19.7% |
| Income Tax | 0 | -9.06M |
| Income Tax % of Revenue | - | -0.3% |
| Net Income (Profit) | 35.05M | -567.39M |
| Profit Margin | - | -19.4% |
Balance Sheet & Liquidity Metrics
| Metric | GENESIS (2025) | ZOTA (2025) |
|---|---|---|
| Cash & Equivalents | 57,000 | 21.32M |
| Total Current Assets | 88.35M | 1.84B |
| Total Current Assets % of Revenue | - | 62.9% |
| Total Current Liabilities | 3.03M | 1.01B |
| Total Current Liabilities % of Revenue | - | 34.3% |
| Long-Term Debt | N/A | 1.08B |
| Long-Term Debt % of Revenue | - | 36.7% |
| Total Shareholders Equity | 85.33M | 2.27B |
| Retained Earnings | -83.06M | -191.89M |
| Retained Earnings % of Revenue | - | -6.5% |
| Property, Plant & Equipment | N/A | 65.25M |
Cash Flow Statement Comparison
| Metric | GENESIS (2025) | ZOTA (2025) |
|---|---|---|
| Operating Cash Flow | 0 | -1.01B |
| Operating Cash Flow % of Revenue | - | -34.4% |
| Capital Expenditures | N/A | -459.67M |
| Free Cash Flow | -3,000 | -959.42M |
| FCF Margin | - | -32.7% |
| Debt Repayment | N/A | -140.67M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GENESIS | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 45.25M | 30.33M |
| Float Shares | N/A | 15.02M |
| % Held by Insiders | 27.24% | 0.00% |
| % Held by Institutions | 0.00% | 1.16% |
| % Held by Public | 72.76% | 98.84% |
Dividend Analysis & Yield Comparison: Genesis IBRC India Ltd. vs Zota Health Care Limited
| Metric | GENESIS | ZOTA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.07% |
| 3-Year Avg Annual Dividend | N/A | ₹1.00 |
| 3-Year Avg Dividend Yield | N/A | 0.16% |
| 3-Year Total Dividends | N/A | ₹3.00 |
| Ex-Dividend Date | N/A | Sep 22, 2025 |